Julianne Averill is a board director, audit committee chair, and healthcare AI executive reimagining how AI shapes financial leadership. With over 20 years of experience working alongside boards and investors in the techbio industry as a CFO, growth-leader, and cross-functional executive, she focuses on using data and emerging technologies to broaden strategic thinking, inform capital decisions, launch innovative products, and help organizations tell more compelling market stories. Julianne has her MS and BS in Business Administration from Fresno State; her certificate in Business Analytics from Harvard University; and is a CPA, NACD.DC, and SHRM-CP certified professional.
